Edwards Lifesciences EW Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.09B-73.8% | $1.07B-74.4% | $1.36B-67.2% | $4.14B+182% | $4.18B+196% | ||
| $160.9M+5.0% | $156.6M+0.9% | $156.5M+4.8% | $151.8M+0.1% | $153.3M+3.4% | ||
| $163.3M+3.4% | $158.1M-2.6% | $150.6M-6.5% | $151.5M-0.1% | $157.9M+8.8% | ||
| $1.36B— | $1.6B— | —— | —— | —— | ||
| $269.1M+10.7% | $260.2M+3.1% | $212.6M-26.9% | $207M-29.7% | $243.1M-5.3% | ||
| $71.1M— | $64.8M— | $77.2M— | $102.6M— | —— | ||
| -$891M— | -$712.9M— | —— | —— | —— | ||
| $1.06B-25.5% | $893.4M-22.9% | $952.9M-36.8% | $1.27B+62.0% | $1.42B+125% | ||
| -$1.2B+9.7% | -$1.01B+0.2% | -$998.1M+29.9% | -$1.23B-109% | -$1.33B-169% | ||
| —— | —— | —— | —— | —— | ||
| $1.09B— | $1.34B— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Edwards Lifesciences generate?
- Edwards Lifesciences (EW) generated $1.4B in operating cash flow over the trailing twelve months.
- What is Edwards Lifesciences's free cash flow?
- After $269.1M of capital expenditures, Edwards Lifesciences's free cash flow was $1.1B over the trailing twelve months, up 57.5% year over year.
- Where does Edwards Lifesciences's cash flow data come from?
- Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
